Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: Correlation with CD38 expression

Laura Ottaggio, Silvia Viaggi, Annalisa Zunino, Simona Zupo, Edoardo Rossi, Mauro Spriano, Angelo Abbondandolo, Manlio Ferrarini

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background and Objectives. B-cell chronic lymphocytic leukemia (B-CLL) results from the accumulation of monoclonal CD5+ B cells. Despite its homogeneity at cellular level, B-CLL is clinically heterogeneous. Clinical studies indicate that CD38+ B-CLL are characterized by a more aggressive clinical course than are CD38- B-CLL. On the basis of these studies and considering the established correlation between specific chromosome aberrations and the clinical course of B-CLL, it is possible that CD38+ B-CLL cases are also characterized by specific subsets of chromosomal alterations. Design and Methods. Comparative genomic hybridization (CGH) was performed on purified B-cells from peripheral blood of 52 patients with B-CLL in order to detect chromosome imbalance. The immunophenotype of the patients, including CD38 expression, was also determined by flow cytometry. The results of CGH experiments were then compared with CD38 expression. Results. We found a clear correlation between the presence of chromosomal imbalances and CD38 expression: 13/16 CD38+ cases had chromosome imbalances, most of them (12/13) correlated with a poor prognosis. Among the CD38- B-CLL patients, only 8/36 displayed chromosome imbalances; the only three cases with loss in 13q as a single aberration, considered a good prognostic marker, were in this group. Moreover, we found that cytogenetic alterations were also more complex in the CD38+ B-CLL subset, since 9/10 with two or more aberrations were in the CD38+ group. Interpretation and Conclusions. Collectively, the data reinforce the value of CD38 as a prognostic factor and indicate that genotypic/phenotypic features distinguish B-CLL subsets.

Original languageEnglish
Pages (from-to)769-777
Number of pages9
JournalHaematologica
Volume88
Issue number7
Publication statusPublished - Jul 1 2003

Fingerprint

Comparative Genomic Hybridization
B-Cell Chronic Lymphocytic Leukemia
Chromosome Aberrations
Chromosomes
B-Lymphocytes
Cytogenetics
Flow Cytometry

Keywords

  • B-CLL
  • CD38
  • Chromosome aberrations
  • Immunophenotype
  • Molecular cytogenetics

ASJC Scopus subject areas

  • Hematology

Cite this

Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia : Correlation with CD38 expression. / Ottaggio, Laura; Viaggi, Silvia; Zunino, Annalisa; Zupo, Simona; Rossi, Edoardo; Spriano, Mauro; Abbondandolo, Angelo; Ferrarini, Manlio.

In: Haematologica, Vol. 88, No. 7, 01.07.2003, p. 769-777.

Research output: Contribution to journalArticle

Ottaggio, L, Viaggi, S, Zunino, A, Zupo, S, Rossi, E, Spriano, M, Abbondandolo, A & Ferrarini, M 2003, 'Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: Correlation with CD38 expression', Haematologica, vol. 88, no. 7, pp. 769-777.
Ottaggio, Laura ; Viaggi, Silvia ; Zunino, Annalisa ; Zupo, Simona ; Rossi, Edoardo ; Spriano, Mauro ; Abbondandolo, Angelo ; Ferrarini, Manlio. / Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia : Correlation with CD38 expression. In: Haematologica. 2003 ; Vol. 88, No. 7. pp. 769-777.
@article{e7b5ced5f4a3499784c36fbbf664fa8a,
title = "Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: Correlation with CD38 expression",
abstract = "Background and Objectives. B-cell chronic lymphocytic leukemia (B-CLL) results from the accumulation of monoclonal CD5+ B cells. Despite its homogeneity at cellular level, B-CLL is clinically heterogeneous. Clinical studies indicate that CD38+ B-CLL are characterized by a more aggressive clinical course than are CD38- B-CLL. On the basis of these studies and considering the established correlation between specific chromosome aberrations and the clinical course of B-CLL, it is possible that CD38+ B-CLL cases are also characterized by specific subsets of chromosomal alterations. Design and Methods. Comparative genomic hybridization (CGH) was performed on purified B-cells from peripheral blood of 52 patients with B-CLL in order to detect chromosome imbalance. The immunophenotype of the patients, including CD38 expression, was also determined by flow cytometry. The results of CGH experiments were then compared with CD38 expression. Results. We found a clear correlation between the presence of chromosomal imbalances and CD38 expression: 13/16 CD38+ cases had chromosome imbalances, most of them (12/13) correlated with a poor prognosis. Among the CD38- B-CLL patients, only 8/36 displayed chromosome imbalances; the only three cases with loss in 13q as a single aberration, considered a good prognostic marker, were in this group. Moreover, we found that cytogenetic alterations were also more complex in the CD38+ B-CLL subset, since 9/10 with two or more aberrations were in the CD38+ group. Interpretation and Conclusions. Collectively, the data reinforce the value of CD38 as a prognostic factor and indicate that genotypic/phenotypic features distinguish B-CLL subsets.",
keywords = "B-CLL, CD38, Chromosome aberrations, Immunophenotype, Molecular cytogenetics",
author = "Laura Ottaggio and Silvia Viaggi and Annalisa Zunino and Simona Zupo and Edoardo Rossi and Mauro Spriano and Angelo Abbondandolo and Manlio Ferrarini",
year = "2003",
month = "7",
day = "1",
language = "English",
volume = "88",
pages = "769--777",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "7",

}

TY - JOUR

T1 - Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia

T2 - Correlation with CD38 expression

AU - Ottaggio, Laura

AU - Viaggi, Silvia

AU - Zunino, Annalisa

AU - Zupo, Simona

AU - Rossi, Edoardo

AU - Spriano, Mauro

AU - Abbondandolo, Angelo

AU - Ferrarini, Manlio

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background and Objectives. B-cell chronic lymphocytic leukemia (B-CLL) results from the accumulation of monoclonal CD5+ B cells. Despite its homogeneity at cellular level, B-CLL is clinically heterogeneous. Clinical studies indicate that CD38+ B-CLL are characterized by a more aggressive clinical course than are CD38- B-CLL. On the basis of these studies and considering the established correlation between specific chromosome aberrations and the clinical course of B-CLL, it is possible that CD38+ B-CLL cases are also characterized by specific subsets of chromosomal alterations. Design and Methods. Comparative genomic hybridization (CGH) was performed on purified B-cells from peripheral blood of 52 patients with B-CLL in order to detect chromosome imbalance. The immunophenotype of the patients, including CD38 expression, was also determined by flow cytometry. The results of CGH experiments were then compared with CD38 expression. Results. We found a clear correlation between the presence of chromosomal imbalances and CD38 expression: 13/16 CD38+ cases had chromosome imbalances, most of them (12/13) correlated with a poor prognosis. Among the CD38- B-CLL patients, only 8/36 displayed chromosome imbalances; the only three cases with loss in 13q as a single aberration, considered a good prognostic marker, were in this group. Moreover, we found that cytogenetic alterations were also more complex in the CD38+ B-CLL subset, since 9/10 with two or more aberrations were in the CD38+ group. Interpretation and Conclusions. Collectively, the data reinforce the value of CD38 as a prognostic factor and indicate that genotypic/phenotypic features distinguish B-CLL subsets.

AB - Background and Objectives. B-cell chronic lymphocytic leukemia (B-CLL) results from the accumulation of monoclonal CD5+ B cells. Despite its homogeneity at cellular level, B-CLL is clinically heterogeneous. Clinical studies indicate that CD38+ B-CLL are characterized by a more aggressive clinical course than are CD38- B-CLL. On the basis of these studies and considering the established correlation between specific chromosome aberrations and the clinical course of B-CLL, it is possible that CD38+ B-CLL cases are also characterized by specific subsets of chromosomal alterations. Design and Methods. Comparative genomic hybridization (CGH) was performed on purified B-cells from peripheral blood of 52 patients with B-CLL in order to detect chromosome imbalance. The immunophenotype of the patients, including CD38 expression, was also determined by flow cytometry. The results of CGH experiments were then compared with CD38 expression. Results. We found a clear correlation between the presence of chromosomal imbalances and CD38 expression: 13/16 CD38+ cases had chromosome imbalances, most of them (12/13) correlated with a poor prognosis. Among the CD38- B-CLL patients, only 8/36 displayed chromosome imbalances; the only three cases with loss in 13q as a single aberration, considered a good prognostic marker, were in this group. Moreover, we found that cytogenetic alterations were also more complex in the CD38+ B-CLL subset, since 9/10 with two or more aberrations were in the CD38+ group. Interpretation and Conclusions. Collectively, the data reinforce the value of CD38 as a prognostic factor and indicate that genotypic/phenotypic features distinguish B-CLL subsets.

KW - B-CLL

KW - CD38

KW - Chromosome aberrations

KW - Immunophenotype

KW - Molecular cytogenetics

UR - http://www.scopus.com/inward/record.url?scp=0037821198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037821198&partnerID=8YFLogxK

M3 - Article

C2 - 12857555

AN - SCOPUS:0037821198

VL - 88

SP - 769

EP - 777

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 7

ER -